Pharmacy Titans Convene in Montreal: Industry Shifts Loom
Baca dalam 60 detik
- The Montreal meeting comes amid escalating drug shortages and regulatory pressures in North America and Europe.
- Pharmacy leaders are prioritizing vertical integration to stabilize supply chains and reduce dependency on overseas manufacturers.
- Data shows 78% of executives cite supply chain fragility as their top risk.
The Montreal meeting comes amid escalating drug shortages and regulatory pressures in North America and Europe. Pharmacy leaders are prioritizing vertical integration to stabilize supply chains and reduce dependency on overseas manufacturers. Data shows 78% of executives cite supply chain fragility as their top risk.
Drug pricing remains the elephant in the room, with upcoming legislation threatening profit margins. Executives are exploring value-based pricing models and outcome-based contracts to preempt government intervention. Industry insiders predict a 15% shift toward such models within two years.
Digital health platforms dominate the innovation agenda, with AI-driven inventory management and telepharmacy services taking center stage. Early adopters report 30% cost reductions in logistics and 20% improvement in patient adherence. The race to digitize is accelerating as margins tighten.
Power Move: The Montreal summit marks a strategic inflection point: pharmacy leaders are no longer reacting to disruption but actively reshaping the landscape. Expect accelerated M&A activity and aggressive digital transformation within 12 months. Those who fail to adapt will lose market share to more agile competitors.
This article was edited with AI assistance for readability. Read original here.
